SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 84 filers reported holding SEELOS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13 | -84.7% | 71 | 0.0% | 0.00% | – |
| Q2 2023 | $85 | +73.5% | 71 | 0.0% | 0.00% | – |
| Q1 2023 | $49 | -63.4% | 71 | -64.0% | 0.00% | – |
| Q4 2022 | $134 | -99.9% | 197 | 0.0% | 0.00% | – |
| Q3 2022 | $203,000 | -96.0% | 197 | -97.4% | 0.00% | – |
| Q2 2022 | $5,100,000 | -26.5% | 7,497 | -9.5% | 0.00% | – |
| Q1 2022 | $6,941,000 | -79.4% | 8,285 | -59.9% | 0.00% | – |
| Q4 2021 | $33,702,000 | -19.2% | 20,676 | +19.5% | 0.00% | – |
| Q3 2021 | $41,707,000 | +441.2% | 17,306 | +492.9% | 0.00% | – |
| Q2 2021 | $7,706,000 | – | 2,919 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,500,000 | $4,075,000 | 1.71% |
| Connacht Asset Management LP | 498,925 | $813,000 | 0.79% |
| GENDELL JEFFREY L | 2,449,267 | $3,992,000 | 0.32% |
| MANGROVE PARTNERS IM, LLC | 2,133,436 | $3,478,000 | 0.21% |
| Uniplan Investment Counsel, Inc. | 1,550,359 | $2,527,000 | 0.14% |
| Financial Advocates Investment Management | 24,673 | $1,994,000 | 0.13% |
| Connacht Asset Management LP | 72,300 | $118,000 | 0.12% |
| Woodline Partners LP | 4,047,231 | $6,597,000 | 0.09% |
| 1492 Capital Management LLC | 108,286 | $177,000 | 0.09% |
| Ikarian Capital, LLC | 244,171 | $398,000 | 0.06% |